Antitumor Biologics - Strategies for Success in an Expanding Market - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/354448

Antitumor Biologics - Strategies for Success in an Expanding Market

Description:

Introduction
Biological agents are essential tools in cancer treatment, particularly as antitumor drugs.
Unsurprisingly, current R&D in this therapeutic area therefore focuses on antitumor agents, predominantly MAbs. While the market is robust—anticancer biologics garnered $9.5 billion in 2005—and expanding, the future for such high-cost drugs is fraught with competitive and financial challenges.

Get the Answers You Need to Shape Your Strategy
Monoclonal antibodies, generating $7.3 billion in sales in 2005, have been the most successful class of biological anticancer agents. What does the future hold for anticancer MAbs?
Genentech’s Herceptin (trastuzumab) recently traversed a clinical path from approval in a small percentage of breast cancer patients to broader use as an early-stage treatment. How can MAbs and other biologics expand into new indications? How can agents leverage off-label use into new approvals and thus vastly expand sales potential?
Third-party payers and patients have expressed concern over the high cost of anticancer biologics, denying off-label use or forgoing treatment altogether. What impact will reimbursement issues have on developing agents?
Emerging agents may place pricing pressures on currently marketed antitumor therapies. How can companies protect the value of current agents? What approaches will manufacturers take to ensure that new drugs will be embraced in the clinic?

Contents:

Executive Summary
Strategic Considerations
Stakeholder Implications
Introduction
Existing Biologic Antitumor Agents
Monoclonal Antibodies
Rituxan
Herceptin
Avastin
Recombinant Cytokines
Targeted Cytotoxins and Radiological Agents
Emerging Antitumor Biologics
Panitumumab
Pertuzumab
Galiximab
Volociximab
Mapatumumab
CAT-3888
CDP-791
Herceptin: A Model for Expanding an Agent’s Reach
Reimbursement Concerns with Anticancer Biologics
Outlook

Tables
1. Select Antitumor Biologic Therapeutic Approaches
2. Current Antitumor Protein Drugs, 2006
3. Select Emerging Antitumor Biologic Agents, 2006
4. Early Stage Approaches to Biological Cancer Treatment
5. Critical Clinical Trial Results for Herceptin

Figures
1. Antibody Structure
2. Number of Anticancer Biologics on the Market, 1995-2006

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/354448

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 02/12/2008 04:12:54

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Antitumor Biologics - Strategies for Success in an Expanding Market
Web Address:
http://www.researchandmarkets.com/reports/354448
Office Code:
OCIFGLKKSPZ

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Single User		€1,325.00

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 02/12/2008 04:12:54

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World